RBOT

SEC source: 0001213900-24-076174 · ownership.xml · nonDerivative · entry 1

Mazzola John · CIK 0001430464 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,990

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $5.58 to $6.27 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

F3 · balance_after: On June 12, 2024, the Issuer effected a 1-for-30 reverse stock split (the "Reverse Stock Split") on its Common Stock. The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001213900-24-076171 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,797

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $5.66 to $6.27 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-071364 · ownership.xml · nonDerivative · entry 2

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,893

F2 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $6.16 to $6.51 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-071369 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,596

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $6.16 to $6.625 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-071366 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,001

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $6.20 to 6.51 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-071364 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,986

F1 · kind: Represents restricted stock units ("RSUs") transferred to the reporting person's ex-spouse pursuant to a divorce decree. The RSUs owned by the ex-spouse are not beneficially owned by the reporting person.

SEC source: 0001013762-24-000388 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,798

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $7.78 to $8.21 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

F3 · balance_after: On June 13, 2024, the Issuer effected a 1-for-30 reverse stock split (the "Reverse Stock Split") on its Common Stock. The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001013762-24-000392 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,294

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $7.78 to $8.21 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

F3 · balance_after: On June 13, 2024, the Issuer effected a 1-for-30 reverse stock split (the "Reverse Stock Split") on its Common Stock. The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001013762-24-000390 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,560

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $7.78 to $8.21 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

F3 · balance_after: On June 13, 2024, the Issuer effected a 1-for-30 reverse stock split (the "Reverse Stock Split") on its Common Stock. The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001213900-24-076173 · ownership.xml · derivative · entry 4

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,735

Underlying: Common Stock · 3,472 shares

Expires 2031-11-22

F1 · kind: The reported transactions involve the reporting person's transfer of shares and stock options to his ex-spouse pursuant to a divorce decree. The shares and stock options owned by the ex-spouse are not beneficially owned by the reporting person.

F6 · derivative.exercise_date: The shares underling this option vest subject to the reporting person's continued service as follows: 218 vested on December 20, 2021, with the remainder vesting in equal monthly installments over the following 36-month period.

F5 · derivative.underlying_shares: On June 12, 2024, the Issuer effected a 1-for-30 reverse stock split (the "Reverse Stock Split") on its Common Stock. The figures reported have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001213900-24-076173 · ownership.xml · derivative · entry 3

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,071

Underlying: Common Stock · 34,143 shares

Expires 2031-02-24

F1 · kind: The reported transactions involve the reporting person's transfer of shares and stock options to his ex-spouse pursuant to a divorce decree. The shares and stock options owned by the ex-spouse are not beneficially owned by the reporting person.

F4 · derivative.exercise_date: The shares underlying this option vest subject to the reporting person's continued service as follows :8,538 vested on January 29, 2022, with the remainder vesting in equal monthly installments over the following 36-month period.

F5 · derivative.underlying_shares: On June 12, 2024, the Issuer effected a 1-for-30 reverse stock split (the "Reverse Stock Split") on its Common Stock. The figures reported have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001213900-24-076173 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,810

F1 · kind: The reported transactions involve the reporting person's transfer of shares and stock options to his ex-spouse pursuant to a divorce decree. The shares and stock options owned by the ex-spouse are not beneficially owned by the reporting person.

SEC source: 0001213900-24-053875 · ownership.xml · derivative · entry 1

Clark Randolph A. · CIK 0002009653 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,490

Underlying: Class A Common Stock · 8,490 shares

Expires 2034-06-16

F1 · derivative.exercise_date: The shares underlying this option vest in equal monthly installments over 48 months beginning on June 17, 2024, subject to Mr. Clark's continued service through the applicable vesting date.

SEC source: 0001213900-24-053880 · ownership.xml · derivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,162

Underlying: Class A Common Stock · 12,162 shares

Expires 2034-06-16

F1 · derivative.exercise_date: The shares underlying this option vest in equal monthly installments over 48 months beginning on June 17, 2024, subject to Mr. Kelly's continued service through the applicable vesting date.

SEC source: 0001213900-24-053878 · ownership.xml · derivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,946

Underlying: Class A Common Stock · 12,946 shares

Expires 2034-06-16

F1 · derivative.exercise_date: The shares underlying this option vest in equal monthly installments over 48 months beginning on June 17, 2024, subject to Mr. Sachs' continued service through the applicable vesting date.

SEC source: 0001213900-24-053877 · ownership.xml · derivative · entry 1

Mazzola John · CIK 0001430464 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,385

Underlying: Class A Common Stock · 6,385 shares

Expires 2034-06-16

F1 · derivative.exercise_date: The shares underlying this option vest in equal monthly installments over 48 months beginning on June 17, 2024, subject to Mr. Mazzola's continued service through the applicable vesting date.

SEC source: 0001213900-24-053876 · ownership.xml · derivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,355

Underlying: Class A Common Stock · 13,355 shares

Expires 2034-06-16

F1 · derivative.exercise_date: The shares underlying this option vest in equal monthly installments over 48 months beginning on June 17, 2024, subject to Mr. Khalifa's continued service through the applicable vesting date.

SEC source: 0001213900-24-051728 · ownership.xml · nonDerivative · entry 1

Ho David D · CIK 0001850976 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 373,661

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-24-051734 · ownership.xml · nonDerivative · entry 1

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,360,129

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-24-051732 · ownership.xml · nonDerivative · entry 1

HUSS BEVERLY A · CIK 0001222352 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,917

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-24-051726 · ownership.xml · nonDerivative · entry 1

Fulop Ric · CIK 0001472305 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,590

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-24-051724 · ownership.xml · nonDerivative · entry 1

CARR BRENDEL VICTORIA · CIK 0001962858 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 254,781

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-24-049598 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 504,767

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.3099 to $0.3399 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-049597 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,691,822

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.3099 to $0.3399 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-049601 · ownership.xml · nonDerivative · entry 1

Mazzola John · CIK 0001430464 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 305,593

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.3099 to $0.3399 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-049600 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,189,209

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.3099 to $0.3399 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-045509 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 511,295

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.3799 to $0.3920 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-045511 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,705,718

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.3799 to $0.3987 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-045510 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,196,376

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.3799 to $0.3988 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-028456 · ownership.xml · nonDerivative · entry 1

Ho David D · CIK 0001850976 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 274,700

F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $13,869.09 of cash retainer fees earned during the first quarter of 2024. The RSUs were fully vested on the grant date.

SEC source: 0001213900-24-024749 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 517,841

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.321 to $0.3511 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-024752 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,730,220

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.3329 to $0.3569 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-024750 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,215,977

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.3294 to $0.3486 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-020148 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 519,131

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.357 to $0.38 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-020150 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,735,050

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.357 to $0.3889 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-020149 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,219,840

F1 · kind: The sales reported in this Form 4 were effecteed to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.357 to $0.381 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-015860 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 526,666

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.35 to $0.3772 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-015862 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,751,090

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.35 to $0.3713 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-015861 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,228,113

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.35 to $0.38 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-24-013812 · ownership.xml · derivative · entry 1

Clark Randolph A. · CIK 0002009653 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Class A Common Stock · 1,000,000 shares

Expires 2034-02-12

F1 · derivative.exercise_date: The shares underlying this option will vest as to 25% on February 13, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Clark's continued service through the applicable vesting date.

SEC source: 0001213900-24-015983 · ownership.xml · derivative · entry 1

Clark Randolph A. · CIK 0002009653 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Class A Common Stock · 1,000,000 shares

Expires 2034-02-12

F1 · derivative.exercise_date: The shares underlying this option will vest as to 25% on February 13, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Clark's continued service through the applicable vesting date.

SEC source: 0001213900-24-000802 · ownership.xml · nonDerivative · entry 1

Ho David D · CIK 0001850976 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 228,702

F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $13,562.50 of cash retainer fees earned during the fourth quarter of 2023. The RSUs were fully vested on the grant date.

SEC source: 0001213900-23-084709 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 534,221

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.4199 to $0.4713 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001013762-23-002456 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 539,205

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.4779 to $0.4951 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001013762-23-001025 · ownership.xml · nonDerivative · entry 2

Ho David D · CIK 0001850976 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,717

F2 · price: RSUs granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $13,562.50 of cash retainer fees earned during the third quarter of 2023. The RSUs were fully vested on the grant date.

SEC source: 0001213900-23-078780 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 544,063

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.7701 to $0.80 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-078775 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,779,372

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.7731 to $0.7998 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-078777 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 580,181

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.7691 to $0.7975 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-078786 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,250,738

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.7701 to $0.7989 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-075087 · ownership.xml · nonDerivative · entry 2

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 545,170

F3 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F4 · price: This figure is the weighted average sales price of multiple trades ranging from $0.961 to $1.005 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.